BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38423594)

  • 1. CUL4A Ubiquitin Ligase Is an Independent Predictor of Overall Survival in Pancreatic Adenocarcinoma.
    Tavlas P; Nikou S; Geramoutsou C; Bosgana P; Tsaniras SC; Melachrinou M; Maroulis I; Bravou V
    Cancer Genomics Proteomics; 2024; 21(2):166-177. PubMed ID: 38423594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of CDT1 Is a Predictor of Poor Survival in Patients with Hepatocellular Carcinoma.
    Karavias D; Maroulis I; Papadaki H; Gogos C; Kakkos S; Karavias D; Bravou V
    J Gastrointest Surg; 2016 Mar; 20(3):568-79. PubMed ID: 26408331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted ubiquitination of CDT1 by the DDB1-CUL4A-ROC1 ligase in response to DNA damage.
    Hu J; McCall CM; Ohta T; Xiong Y
    Nat Cell Biol; 2004 Oct; 6(10):1003-9. PubMed ID: 15448697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung tumourigenesis in a conditional Cul4A transgenic mouse model.
    Yang YL; Hung MS; Wang Y; Ni J; Mao JH; Hsieh D; Au A; Kumar A; Quigley D; Fang LT; Yeh CC; Xu Z; Jablons DM; You L
    J Pathol; 2014 Jun; 233(2):113-23. PubMed ID: 24648314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CUL4A ubiquitin ligase is a potential therapeutic target in skin cancer and other malignancies.
    Hannah J; Zhou PB
    Chin J Cancer; 2013 Sep; 32(9):478-82. PubMed ID: 23845142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of CUL4A and CUL4B Ubiquitin Ligases in Lung Cancer.
    Jia L; Yan F; Cao W; Chen Z; Zheng H; Li H; Pan Y; Narula N; Ren X; Li H; Zhou P
    J Biol Chem; 2017 Feb; 292(7):2966-2978. PubMed ID: 27974468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of the Cdc6 replication licensing factor in metazoa: the role of nuclear export and the CUL4 ubiquitin ligase.
    Kim J; Kipreos ET
    Cell Cycle; 2008 Jan; 7(2):146-50. PubMed ID: 18256526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRL4A
    Feng M; Wang Y; Bi L; Zhang P; Wang H; Zhao Z; Mao JH; Wei G
    Oncogene; 2021 Mar; 40(11):2096-2111. PubMed ID: 33627782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two E3 ubiquitin ligases, SCF-Skp2 and DDB1-Cul4, target human Cdt1 for proteolysis.
    Nishitani H; Sugimoto N; Roukos V; Nakanishi Y; Saijo M; Obuse C; Tsurimoto T; Nakayama KI; Nakayama K; Fujita M; Lygerou Z; Nishimoto T
    EMBO J; 2006 Mar; 25(5):1126-36. PubMed ID: 16482215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Licensing Factor Cdt1 Links Cell Cycle Progression to the DNA Damage Response.
    Kanellou A; Giakoumakis NN; Panagopoulos A; Tsaniras SC; Lygerou Z
    Anticancer Res; 2020 May; 40(5):2449-2456. PubMed ID: 32366388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DDB1 maintains genome integrity through regulation of Cdt1.
    Lovejoy CA; Lock K; Yenamandra A; Cortez D
    Mol Cell Biol; 2006 Nov; 26(21):7977-90. PubMed ID: 16940174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evolutionarily conserved function of proliferating cell nuclear antigen for Cdt1 degradation by the Cul4-Ddb1 ubiquitin ligase in response to DNA damage.
    Hu J; Xiong Y
    J Biol Chem; 2006 Feb; 281(7):3753-6. PubMed ID: 16407242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of DNA Replication Licensing and Re-Replication by Cdt1.
    Zhang H
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CUL4
    Wang Y; Yan F; Nasar A; Chen ZS; Altorki NK; Stiles B; Narula N; Zhou P
    Am J Pathol; 2021 Sep; 191(9):1638-1650. PubMed ID: 34119472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitotic UV irradiation induces a DNA replication-licensing defect that potentiates G1 arrest response.
    Morino M; Nukina K; Sakaguchi H; Maeda T; Takahara M; Shiomi Y; Nishitani H
    PLoS One; 2015; 10(3):e0120553. PubMed ID: 25798850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches.
    Jiang J; Zhang Y; Wang J; Yang X; Ren X; Huang H; Wang J; Lu J; Zhong Y; Lin Z; Lin X; Jia Y; Lin S
    PeerJ; 2023; 11():e16166. PubMed ID: 37790630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cullin 4A is associated with epithelial to mesenchymal transition and poor prognosis in perihilar cholangiocarcinoma.
    Zhang TJ; Xue D; Zhang CD; Zhang ZD; Liu QR; Wang JQ
    World J Gastroenterol; 2017 Apr; 23(13):2318-2329. PubMed ID: 28428711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redundant and differential regulation of multiple licensing factors ensures prevention of re-replication in normal human cells.
    Sugimoto N; Yoshida K; Tatsumi Y; Yugawa T; Narisawa-Saito M; Waga S; Kiyono T; Fujita M
    J Cell Sci; 2009 Apr; 122(Pt 8):1184-91. PubMed ID: 19339550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L2DTL/CDT2 interacts with the CUL4/DDB1 complex and PCNA and regulates CDT1 proteolysis in response to DNA damage.
    Higa LA; Banks D; Wu M; Kobayashi R; Sun H; Zhang H
    Cell Cycle; 2006 Aug; 5(15):1675-80. PubMed ID: 16861906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cullin-4A·DNA damage-binding protein 1 E3 ligase complex targets tumor suppressor RASSF1A for degradation during mitosis.
    Jiang L; Rong R; Sheikh MS; Huang Y
    J Biol Chem; 2011 Mar; 286(9):6971-8. PubMed ID: 21205828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.